The manufactured depression crisis: How $9 billion in antidepressant sales pathologized normal human sadness
Antidepressant market valued at $6.9 billion in 2022, projected to reach $9.37 billion by 2030.
Depression diagnosis rates surged from 3.33% to 17.8% of Americans between 1992 and 2025.
Pharmaceutical industry funding creates conflict of interest with FDA regulatory oversight.
Gut-brain connection research shows 95% of serotonin produced in digestive system.
Nutritional deficiencies, hormone imbalances and gut health issues offer alternative treatment pathways.
Read Full Article: https://www.naturalnews.com/2026-07-08-manufactured-depression-crisis-antidepressant-sales-pathologized-sadness.html
